Barclays PLC lifted its position in RXO, Inc. (NYSE:RXO – Free Report) by 185.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 908,873 shares of the company’s stock after buying an additional 590,530 shares during the quarter. Barclays PLC owned approximately 0.57% of RXO worth $25,449,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Nomura Asset Management Co. Ltd. lifted its stake in RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after purchasing an additional 570 shares in the last quarter. GAMMA Investing LLC raised its position in shares of RXO by 40.0% in the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after buying an additional 510 shares in the last quarter. Canada Pension Plan Investment Board bought a new stake in RXO during the second quarter valued at $112,000. KBC Group NV grew its position in RXO by 28.1% during the third quarter. KBC Group NV now owns 4,055 shares of the company’s stock worth $114,000 after buying an additional 890 shares in the last quarter. Finally, City Holding Co. grew its position in RXO by 57.9% during the third quarter. City Holding Co. now owns 5,241 shares of the company’s stock worth $147,000 after buying an additional 1,921 shares in the last quarter. 92.73% of the stock is currently owned by institutional investors.
RXO Stock Down 3.5 %
Shares of NYSE RXO opened at $27.29 on Friday. The firm’s fifty day moving average is $28.70 and its 200 day moving average is $27.21. RXO, Inc. has a 52 week low of $18.75 and a 52 week high of $32.82. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. The company has a market cap of $4.39 billion, a price-to-earnings ratio of -13.78, a PEG ratio of 16.74 and a beta of 1.32.
Analyst Upgrades and Downgrades
RXO has been the subject of a number of research analyst reports. The Goldman Sachs Group reiterated a “neutral” rating and set a $29.00 price target on shares of RXO in a research report on Monday, November 18th. Citigroup cut shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective on the stock. in a research report on Tuesday, November 12th. Benchmark reissued a “hold” rating on shares of RXO in a research note on Tuesday, October 15th. Susquehanna dropped their price target on RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. Finally, Oppenheimer reiterated an “outperform” rating and set a $31.00 price objective on shares of RXO in a research report on Tuesday, September 17th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, RXO currently has an average rating of “Hold” and an average target price of $26.47.
Get Our Latest Stock Analysis on RXO
RXO Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Further Reading
- Five stocks we like better than RXO
- What to Know About Investing in Penny Stocks
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RXO, Inc. (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.